GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 385.13
-1.69 (-0.44%)
At close: Dec 23, 2025
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 122.88 billion as of December 23, 2025. Its market cap has decreased by -0.09% in one year.
Market Cap
122.88B
Enterprise Value
116.24B
Revenue
62.07B
Ranking
n/a
PE Ratio
13.37
Stock Price
385.13
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 122.88B, an increase of 3,158.70%. That is a compound annual growth rate of 11.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 123.19B | -2.54% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | 61.09B | 19.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 103.67B |
| The Searle Company | 64.75B |
| Highnoon Laboratories | 54.47B |
| AGP Limited | 53.28B |
| Shifa International Hospitals | 32.07B |
| Citi Pharma | 20.01B |
| Ferozsons Laboratories | 16.13B |
| Macter International | 15.35B |